Literature DB >> 20143115

A strategy to avoid facial mutilation in orbital embryonal rhabdomyosarcoma.

Stefan Zwerger1, Lutz Günther, Arnulf Pekrun, Heico-Rüdiger Krause, Jan Rustemeyer.   

Abstract

INTRODUCTION: An orbital embryonal rhabdomyosarcoma (RMS) is a rare malignancy in children, but clinical findings are typical. We detail the case of an 8-year-old female with orbital RMS and discuss the therapeutic options. CASE REPORT: Orbital RMS was apparent with painless exophthalmos of the right globe and diplopia. Head MRI showed tumor masses behind and inferior to the globe. Open biopsy led to the histological diagnosis. Metastasis or infiltration of orbital bone was not observed. Chemotherapy was carried out in accordance with the Cooperative Weichteilsarkom Studie (CWS) 2002 protocol. Tumor regression was detected after the first course of chemotherapy; we decided to excise the residual tumor with preservation of the globe. The CWS 2002 protocol was subsequently completed. Radiotherapy was not done. One year after treatment, RMS recurrence was not observed.
CONCLUSION: After interdisciplinary treatment, mutilation was avoided after exenteration of the orbit or radiation treatment to the growing facial skeleton. That was possible due to excision of the residual tumor in a second step, leading to down-staging of the RMS.

Entities:  

Mesh:

Year:  2010        PMID: 20143115     DOI: 10.1007/s10006-009-0197-x

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  23 in total

Review 1.  Orbital rhabdomyosarcoma.

Authors:  Zeynel A Karcioglu; Doris Hadjistilianou; Marta Rozans; Sonia DeFrancesco
Journal:  Cancer Control       Date:  2004 Sep-Oct       Impact factor: 3.302

Review 2.  Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

Authors:  R B Raney; J R Anderson; F G Barr; S S Donaldson; A S Pappo; S J Qualman; E S Wiener; H M Maurer; W M Crist
Journal:  J Pediatr Hematol Oncol       Date:  2001-05       Impact factor: 1.289

3.  How much is enough? The continuing evolution of therapy in childhood rhabdomyosarcoma and its refinement.

Authors:  J R Cassady
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-02-01       Impact factor: 7.038

4.  Clinical spectrum of primary ophthalmic rhabdomyosarcoma.

Authors:  C L Shields; J A Shields; S G Honavar; H Demirci
Journal:  Ophthalmology       Date:  2001-12       Impact factor: 12.079

5.  Orbital abscess masquerading as a rhabdomyosarcoma.

Authors:  N Cota; A Chandna; L J Abernethy
Journal:  J AAPOS       Date:  2000-10       Impact factor: 1.220

Review 6.  Issues in the local control of rhabdomyosarcoma.

Authors:  J C Breneman; E S Wiener
Journal:  Med Pediatr Oncol       Date:  2000-08

7.  Parameningeal rhabdomyosarcoma (including the orbit): results of orbital irradiation.

Authors:  B Jereb; B G Haik; R Ong; F Ghavimi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-12       Impact factor: 7.038

8.  The Intergroup Rhabdomyosarcoma Study-II.

Authors:  H M Maurer; E A Gehan; M Beltangady; W Crist; P S Dickman; S S Donaldson; C Fryer; D Hammond; D M Hays; J Herrmann
Journal:  Cancer       Date:  1993-03-01       Impact factor: 6.860

9.  Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study.

Authors:  W A Newton; E A Gehan; B L Webber; H B Marsden; A J van Unnik; A B Hamoudi; M G Tsokos; H Shimada; D Harms; D Schmidt
Journal:  Cancer       Date:  1995-09-15       Impact factor: 6.860

Review 10.  Rhabdomyosarcoma: review for the ophthalmologist.

Authors:  Jerry A Shields; Carol L Shields
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.